136 related articles for article (PubMed ID: 24964238)
1. The quality of life of non-small cell lung cancer patients treated with chemotherapy.
Karczmarek-Borowska B; Pelc M; Rabiej E; Grądalska-Lampart M
Pneumonol Alergol Pol; 2014; 82(4):349-57. PubMed ID: 24964238
[TBL] [Abstract][Full Text] [Related]
2. [Quality of life assessment in patients with non-small cell lung cancer treated surgically or with pre-operative chemotherapy followed by surgery].
Wachowicz M; Furmanik F
Pneumonol Alergol Pol; 2003; 71(3-4):121-31. PubMed ID: 14587417
[TBL] [Abstract][Full Text] [Related]
3. Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-blind, phase 3 study.
Belani CP; Brodowicz T; Ciuleanu TE; Krzakowski M; Yang SH; Franke F; Cucevic B; Madhavan J; Santoro A; Ramlau R; Liepa AM; Visseren-Grul C; Peterson P; John WJ; Zielinski CC
Lancet Oncol; 2012 Mar; 13(3):292-9. PubMed ID: 22336221
[TBL] [Abstract][Full Text] [Related]
4. Influence of clinical parameters on quality of life during chemotherapy in patients with advanced non-small cell lung cancer: application of a general linear model.
Morita S; Kobayashi K; Eguchi K; Matsumoto T; Shibuya M; Yamaji Y; Sakamoto J; Ohashi Y
Jpn J Clin Oncol; 2003 Sep; 33(9):470-6. PubMed ID: 14594941
[TBL] [Abstract][Full Text] [Related]
5. Clinical decision-making and health-related quality of life during first-line and maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC): findings from a real-world setting.
Sztankay M; Giesinger JM; Zabernigg A; Krempler E; Pall G; Hilbe W; Burghuber O; Hochmair M; Rumpold G; Doering S; Holzner B
BMC Cancer; 2017 Aug; 17(1):565. PubMed ID: 28835219
[TBL] [Abstract][Full Text] [Related]
6. Perception of alopecia by patients requiring chemotherapy for non-small-cell lung cancer: a willingness to pay study.
Bernard M; Brignone M; Adehossi A; Pefoura S; Briquet C; Chouaid C; Tilleul P
Lung Cancer; 2011 Apr; 72(1):114-8. PubMed ID: 20701993
[TBL] [Abstract][Full Text] [Related]
7. The effects of illness beliefs and chemotherapy impact on quality of life in Japanese and Dutch patients with breast or lung cancer.
van der Kloot WA; Uchida Y; Inoue K; Kobayashi K; Yamaoka K; Nortier HW; Kaptein AA
Chin Clin Oncol; 2016 Feb; 5(1):3. PubMed ID: 26932427
[TBL] [Abstract][Full Text] [Related]
8. Lung cancer and quality of life.
Thongprasert S
Aust N Z J Med; 1998 Jun; 28(3):397-9. PubMed ID: 9673757
[TBL] [Abstract][Full Text] [Related]
9. [The quality of life after chemotherapy in advanced non-small cell lung cancer patients].
Słowik-Gabryelska A; Szczepanik A; Kalicka A
Pol Merkur Lekarski; 1999 Jan; 6(31):18-22. PubMed ID: 10344148
[TBL] [Abstract][Full Text] [Related]
10. Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life. A randomized controlled trial.
Belani CP; Pereira JR; von Pawel J; Pluzanska A; Gorbounova V; Kaukel E; Mattson KV; Ramlau R; Szczesna A; Fidias P; Millward M; Fossella F;
Lung Cancer; 2006 Aug; 53(2):231-9. PubMed ID: 16787687
[TBL] [Abstract][Full Text] [Related]
11. Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer.
Brown J; Thorpe H; Napp V; Fairlamb DJ; Gower NH; Milroy R; Parmar MK; Rudd RM; Spiro SG; Stephens RJ; Waller D; West P; Peake MD
J Clin Oncol; 2005 Oct; 23(30):7417-27. PubMed ID: 16157935
[TBL] [Abstract][Full Text] [Related]
12. Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced nonsmall-cell lung cancer (NSCLC) who are 70 years of age or older.
Simon GR; Extermann M; Chiappori A; Williams CC; Begum M; Kapoor R; Haura EB; Ismail-Khan R; Schell MJ; Antonia SJ; Bepler G
Cancer; 2008 May; 112(9):2021-9. PubMed ID: 18300255
[TBL] [Abstract][Full Text] [Related]
13. Quality of life, symptom experience and distress of lung cancer patients undergoing chemotherapy.
Akin S; Can G; Aydiner A; Ozdilli K; Durna Z
Eur J Oncol Nurs; 2010 Dec; 14(5):400-9. PubMed ID: 20149733
[TBL] [Abstract][Full Text] [Related]
14. [Comparative study on quality of life between weekly and monthly chemotherapy with cisplatin, vindesine and mitomycin C in patients with non-small cell lung cancer].
Ishihara Y; Ichiwata T; Kuramitsu K; Yoneda S; Yamamoto M; Takizawa T; Ogata T; Uchiyama T; Yoshida K
Gan To Kagaku Ryoho; 1998 Jun; 25(7):1013-20. PubMed ID: 9644316
[TBL] [Abstract][Full Text] [Related]
15. How best to assess the quality of life in long-term survivors after surgery for NSCLC? Comparison between clinical predictors and questionnaire scores.
Sterzi S; Cesario A; Cusumano G; Corbo G; Lococo F; Biasotti B; Lapenna LM; Magrone G; Dall'armi V; Meacci E; Porziella V; Bonassi S; Margaritora S; Granone P
Clin Lung Cancer; 2013 Jan; 14(1):78-87. PubMed ID: 22607778
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life in advanced non-small cell lung cancer: correlates and comparisons to normative data.
Larsson M; Ljung L; Johansson BB
Eur J Cancer Care (Engl); 2012 Sep; 21(5):642-9. PubMed ID: 22519874
[TBL] [Abstract][Full Text] [Related]
17. Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: a randomised phase II study.
Bar-Sela G; Wollner M; Hammer L; Agbarya A; Dudnik E; Haim N
Eur J Cancer; 2013 Mar; 49(5):1058-64. PubMed ID: 23218588
[TBL] [Abstract][Full Text] [Related]
18. The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, Stage IIIB or IV nonsmall cell lung carcinoma treated with carboplatin and paclitaxel.
Hensing TA; Peterman AH; Schell MJ; Lee JH; Socinski MA
Cancer; 2003 Aug; 98(4):779-88. PubMed ID: 12910523
[TBL] [Abstract][Full Text] [Related]
19. Changes in and Determinants of Quality of Life in Patients With Advanced Non-Small-Cell Lung Cancer Undergoing Initial Chemotherapy.
Dai YL; Yang CT; Chen KH; Tang ST
J Nurs Res; 2017 Jun; 25(3):203-215. PubMed ID: 28481816
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with the likelihood of receiving second line therapy for advanced non-small cell lung cancer.
Hensing TA; Schell MJ; Lee JH; Socinski MA
Lung Cancer; 2005 Feb; 47(2):253-9. PubMed ID: 15639724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
